Radformation’s Automation Solutions Achieve MDR CE Mark
New York, NY, February 5, 2025
Radformation, Inc., a global pioneer in radiation oncology software solutions, is proud to announce that AutoContour, ClearCheck, ClearCalc, and ChartCheck have achieved the EU Medical Device Regulation (MDR) CE Mark certification. This certification verifies that Radformation complies with the European Union’s (EU) Regulation 2017/745 and other recognized standards, ensuring adherence to stringent health, safety, and environmental protection standards.
As the global cancer burden continues to rise, Radformation solutions play a crucial role in accelerating every stage of the radiation oncology workflow. By automating critical, yet-time intensive tasks, Radformation empowers clinicians to prioritize quality care, ensuring patients receive faster access to treatment.
With MDR CE Mark certification, clinics across Europe and other countries where the CE Mark is accepted, can now leverage these tools:
                                AutoContour: Improves treatment planning by
                                significantly reducing the time required for manual contouring, providing AI-driven, clinically-validated
                                contours within minutes.
                                
                                ClearCheck: Automates plan quality checks to
                                ensure compliance with clinical standards, improving plan quality and documentation accuracy.
                                
                                ClearCalc: Provides independent dose calculation
                                verification, patient-specific quality assurance, and gold-standard radiotherapy calculation with
                                RadMonteCarlo, to instill confidence in
                                treatment accuracy while boosting efficiency and streamlining QA processes
                                
                                ChartCheck: Actively monitors patient data in
                                real-time for automated safety and compliance checks during treatment delivery.
                            
“Achieving MDR CE Mark is a significant milestone in Radformation’s mission to advance global cancer care,” said Kurt Sysock, CEO at Radformation. “We are excited to bring our solutions to CE mark regions, empowering clinics to enhance efficiency and safety in their workflows.”
About Radformation
                                    Radformation is committed to improving the lives of
                                    clinicians by delivering user-friendly products developed to increase the safety and quality of cancer
                                    treatment. Radformation envisions a radiation oncology clinic where staff are equipped with solutions
                                    that supplement their expertise and automate time-consuming tasks, leading to better patient care
                                    everywhere. Since its founding in 2016, Radformation has grown to serve over 2,000 clinics around the
                                    world in 28 countries with a portfolio of products accelerating all stages of the treatment planning
                                    workflow. For more information, visit radformation.com. 
                                
                                
                                Source:
                                Melanie Benton
                                Director of Marketing, Radformation
                                mbenton@radformation.com